The Healthcare News Diaries
Novo CEO pressed by Senate to chop rates of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into account new talks with insurers with regard to the list charges of Wegovy and copyright if they pledge to help keep the medicines on their own formularies.Sanders quickly condemned